![Chris Achar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Achar
Vorstandsvorsitzender bei Genzum Life Sciences, Inc.
Vermögen: 136 609 $ am 31.05.2024
Aktive Positionen von Chris Achar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genzum Life Sciences, Inc. | Vorstandsvorsitzender | 01.01.2020 | - |
The Network for Teaching Entrepreneurship
![]() The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Direktor/Vorstandsmitglied | 01.01.2018 | - |
GenZum Life Sciences LLC
![]() GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Vorstandsvorsitzender | 01.01.2010 | - |
Karriereverlauf von Chris Achar
Ehemalige bekannte Positionen von Chris Achar
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CUE HEALTH INC. | Direktor/Vorstandsmitglied | 01.05.2018 | 24.05.2024 |
Corporate Officer/Principal | 01.06.2021 | 24.05.2024 |
Ausbildung von Chris Achar
The California State University | Undergraduate Degree |
Pepperdine Graziadio Business School | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 6 |
2 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CUE HEALTH INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
The Network for Teaching Entrepreneurship
![]() The Network for Teaching Entrepreneurship Miscellaneous Commercial ServicesCommercial Services The Network for Teaching Entrepreneurship (NFTE) is a non-profit organization that provides entrepreneurship education to middle school, high school, and postsecondary students in 30 states and 31 countries. The non-profit company is based in New York, NY. NFTE aims to ignite the entrepreneurial mindset in students, empowering them to own their futures regardless of their family income, community resources, special needs, gender identity, race, or ethnicity. NFTE has educated over a million students through in-school, out-of-school, in-person, online, or hybrid programs. The company was founded in 1987 by Carl Press and Philip A. McNeill, and J.D. LaRock has been the CEO of the company since 2019. | Commercial Services |
GenZum Life Sciences LLC
![]() GenZum Life Sciences LLC Pharmaceuticals: MajorHealth Technology GenZum Life Sciences LLC operates as a pharmaceutical product development and out licensing company. It operates throughout the pharmaceutical development cycle and from product selection and formulation to clinical trials and FDA approval, Genzum product lines have been in-licensed by pharmaceutical companies, decreasing costs, increasing market value and improving the lives of many. The firm utilizes an innovative ecosystem of best in class facilities and expert pharmaceutical development and clinical trials capabilities. The company was founded by Rajin K. Ahuja and Chris K. Achar in 2008 and is headquartered in Los Angeles, CA. | Health Technology |
Genzum Life Sciences, Inc. |
- Börse
- Insiders
- Chris Achar
- Erfahrung